https://www.selleckchem.com/pr....oducts/ly3023414.htm
66; 95%CI 0.5-0.87; I2 = 83%). The certainty in the evidence was low. CONCLUSION In this systematic review and meta-analysis, we observed no difference in risk of RA in statin users vs non-users. Risk of RA may be lower in patients with higher versus lower statin treatment persistence or intensity. Future observational studies with guards against selection bias and confounding are needed to further elucidate the impact of statin use on the risk of RA, considering potential differences by dosage, duration of use, study population and o
Like
Comment
Share
